Login / Signup

[Local application of recombinant activated factor VII for massive surgical bleeding].

A Yu LubninD Yu UsachevA A KurbasovA V ShmigelskyG I GvazavaNatalia Tarasova
Published in: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko (2021)
The authors report resection of anaplastic convexital meningioma in a middle-aged woman complicated by expected massive blood loss. The most intense bleeding occurred at the final stage of resection and it was impossible to stop it with traditional approaches. The surgeon pressed a standard tachocomb plate moistened with a diluted solution of recombinant activated factor VII (coagil, Russia) to the most bleeding area for 5 minutes. Subsequently, surgeon replaced finger pressure with a permanent napkin. Hemostatic effect of recombinant activated factor VII following its systemic administration is well known and convincingly proven in many surgical areas including neurosurgery. However, we do not know any descriptions of its local application in neurosurgical patients.
Keyphrases
  • atrial fibrillation
  • end stage renal disease
  • middle aged
  • ejection fraction
  • newly diagnosed
  • cell free
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • robot assisted
  • patient reported outcomes